Brief: New Ray Medicine International Says Estimated Loss For FY22 May Be Increased To HK$77.9 Mln
22/03/2023 13:30
March 22 (Reuters) - New Ray Medicine International
Holding Ltd 6108.HK :
* ESTIMATED EXPECTED LOSS FOR FY 2022 MAY BE INCREASED TO
HK$77.9
MILLION
Source text for Eikon: ID:
Further company coverage: 6108.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on New Ray Medicine International Holding
See all newsBrief: New Ray Medicine International Holding Says Chu Xueping Resigns As Executive Director
Brief: New Ray Medicine International Posts FY Net Loss Attributable HK$20.1 Million
Brief: New Ray Medicine International To Place Up To 33.4 Million Shares
Brief: New Ray Medicine International Says China New Rich Enters Cooperation Agreement
Brief: New Ray Medicine International Says Unit Disposes 801,000 Jiangxi Rimag Shares For HK$12.8 Million